Juniper Pharma (JNP) Misses Q1 EPS by 9c

Juniper Pharma (NASDAQ: JNP) reported Q1 EPS of ($0.06), $0.09 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $7.8 million.

Adjusted EBITDA was $0.4 million in the first quarter of 2015 compared with $0.5 million in the first quarter of 2014.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat